List view / Grid view
Scientists in Switzerland have developed a new means of crystallising membrane proteins – a hitherto elusive feat – in order to study their structure and aid understanding of their processes.
Cellular imaging acquisition and analysis system at an affordable price point.
Researchers have developed the first-ever high-throughput, genome-scale imaging-based approach to investigate protein stability...
Researchers in Japan have ramped up nature’s wonder that is bioluminescence to enable deep tissue cells to be seen from outside the body.
A research team has discovered the process - and filmed the actual moment - that can change the body’s response to a dying cell.
Researchers have found that excess levels of calcium in brain cells may lead to the formation of toxic clusters that are the hallmark of Parkinson's disease...
An MRI technique that requires no contrast agent, combined with sophisticated data analysis, could reduce the number of unnecessary breast biopsies...
Researchers have uncovered the architecture of the spindle pole body in yeast...
Researchers report the successful use of heart imaging to predict the benefit or futility of catheter ablation...
Using nuclear medicine, German researchers have found a way to accurately differentiate cancerous tissue from healthy tissue in prostate cancer patients.
Researchers have made an important step forward in the design of drugs that fight the hepatitis B virus, which can cause liver failure and liver cancer...
A nuclear medicine scan may locate prostate cancer recurrence after radical prostatectomy early after disease recurrence and could help guide salvage radiotherapy...
1 February 2018 | By PerkinElmer
This webinar discussed a screening assay that recapitulates the activation of ER stress sensor IRE1 and an assay to quantify cell migration phenotypes, as applied to cardiovascular target validation and drug discovery.
Crystal structure of the dopamine 2 receptor bound to an antipsychotic drug provides a much-needed discovery in the quest to create effective drugs with fewer side effects...
Reasons for phenotypic vs. target based drug discovery strategies, challenges of and maximising return of phenotypic assays.
